Regencell Bioscience: Extended Lock-Up Creates Significant Upside Potential
Source: SeekingAlpha
2026-03-06 09:06:03 ET
Regencell Bioscience Holdings Limited ( RGC ), a company focused on the development of Traditional Chinese Medicine ((TCM)) remedies for Attention Deficit Hyperactivity Disorder ((ADHD)) and Autism, is up a staggering 23,745% over the last year. The market capitalization now stands at $12.6b. This gives Chairman, CEO and Founder Yat-Gai Au a net worth of over $10b. Regencell has zero revenue and is unlikely to ever generate revenue....
Read the full article on Seeking Alpha
For further details see:
Regencell Bioscience: Extended Lock-Up Creates Significant Upside Potential
Regencell Bioscience Holdings Limited
NASDAQ: RGC
RGC Trading
-4.04% G/L:
$23.02 Last:
48,244 Volume:
$23.90 Open:
RGC Latest News
March 06, 2026 09:35:00 pm
Here's Why I Wouldn't Touch Regencell Bioscience With a 10?Foot Pole Right Now
March 05, 2026 05:20:00 pm
Don't Even Think About Buying Regencell Bioscience Stock Until You See This 1 Red Flag
March 01, 2026 12:23:00 pm
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need
RGC Stock Data
$13,173,184,509
55,382,758
N/A
7
N/A
Pharmaceuticals
Healthcare
HK
Hong Kong
